Imatinib Mesylate Tablet, Film Coated
Product Images NDC 0378-2246
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Imatinib Mesylate (NDC 0378-2246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Progression Free Survival (itt Principle) (Image 02)
Time To Progression To Ap Or Bc (itt Principle) (Image 03)
Study 1 Recurrence-free Survival (itt Population) (Image 04)
Study 2 Recurrence-free Survival (itt Population) (Image 05)
Study 2 Overall Survival (itt Population) (Image 06)
Imatinib Mesylate Tablets 100 mg Bottle Label (Image 07)
Imatinib Mesylate Tablets 400 mg Bottle Label (Image 08)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.